Total Payments
$717.67
2024 Payments
$19.65
Companies
12
Transactions
21
Medicare Patients
2,977
Medicare Billing
$430,419
Payment Breakdown by Category
Food & Beverage$717.67 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $717.67 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $202.82 | 3 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $92.67 | 1 | $0 (2017) |
| Allergan Inc. | $86.54 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $53.53 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $51.70 | 2 | $0 (2023) |
| Gilead Sciences, Inc. | $47.55 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $42.23 | 2 | $0 (2021) |
| ABBVIE INC. | $41.87 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $39.03 | 2 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $25.08 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.65 | 1 | Philips North America LLC ($19.65) |
| 2023 | $47.21 | 2 | Novartis Pharmaceuticals Corporation ($30.78) |
| 2022 | $97.63 | 5 | Janssen Pharmaceuticals, Inc ($53.53) |
| 2021 | $127.45 | 6 | Gilead Sciences, Inc. ($47.55) |
| 2020 | $22.78 | 1 | GlaxoSmithKline, LLC. ($22.78) |
| 2019 | $38.48 | 2 | Novartis Pharmaceuticals Corporation ($20.92) |
| 2018 | $93.50 | 1 | PFIZER INC. ($93.50) |
| 2017 | $270.97 | 3 | Synergy Pharmaceuticals Inc ($92.67) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | Philips North America LLC | (5050) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $19.65 | General |
| Category: Medical Device | ||||||
| 03/17/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/15/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiovascular | ||||||
| 09/28/2021 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.08 | General |
| 09/28/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.24 | General |
| 09/17/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/02/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.31 | General |
| 07/30/2021 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: ONCOLOGY | ||||||
| 08/11/2020 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/26/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $93.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2017 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $92.67 | General |
| Category: Gastroenterology | ||||||
| 08/30/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $86.54 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/04/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $91.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 834 | 1,021 | $974,050 | $119,726 |
| 2022 | 7 | 843 | 1,054 | $1.0M | $127,121 |
| 2021 | 8 | 727 | 1,102 | $412,217 | $103,409 |
| 2020 | 8 | 573 | 717 | $408,418 | $80,163 |
Total Patients
2,977
Total Services
3,894
Medicare Billing
$430,419
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 439 | 445 | $670,705 | $63,127 | 9.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 302 | 480 | $255,806 | $47,906 | 18.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 75 | 75 | $36,505 | $7,365 | 20.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 21 | $11,033 | $1,330 | 12.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 315 | 322 | $478,740 | $52,393 | 10.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 340 | 346 | $394,449 | $50,241 | 12.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 252 | $47,674 | $14,054 | 29.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 56 | 74 | $63,457 | $6,242 | 9.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 30 | 30 | $8,869 | $2,498 | 28.2% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 11 | 13 | $11,253 | $1,135 | 10.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 17 | $2,775 | $558.78 | 20.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 194 | 536 | $76,715 | $32,052 | 41.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 176 | 178 | $151,203 | $29,959 | 19.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 176 | 177 | $136,336 | $26,522 | 19.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 77 | 81 | $18,685 | $7,177 | 38.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 33 | 42 | $19,442 | $3,619 | 18.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 23 | 24 | $3,395 | $1,416 | 41.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 26 | 42 | $3,360 | $1,340 | 39.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 22 | 22 | $3,080 | $1,323 | 43.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 171 | 174 | $135,513 | $28,895 | 21.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 180 | 181 | $139,591 | $25,687 | 18.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 97 | 207 | $59,163 | $12,725 | 21.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 57 | 80 | $42,462 | $6,868 | 16.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 29 | 29 | $14,193 | $2,624 | 18.5% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 15 | 22 | $9,789 | $1,901 | 19.4% |
About Dr. Ramesh Kumar, M.D
Dr. Ramesh Kumar, M.D is a Hospitalist healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083894604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramesh Kumar, M.D has received a total of $717.67 in payments from pharmaceutical and medical device companies, with $19.65 received in 2024. These payments were reported across 21 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($717.67).
As a Medicare-enrolled provider, Kumar has provided services to 2,977 Medicare beneficiaries, totaling 3,894 services with total Medicare billing of $430,419. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine, Internal Medicine
- Location Paducah, KY
- Active Since 11/12/2007
- Last Updated 02/19/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1083894604
Products in Payments
- ELIQUIS (Drug) $217.82
- Trulance (Drug) $92.67
- DALVANCE (Drug) $86.54
- XARELTO (Drug) $53.53
- ENTRESTO (Drug) $51.70
- BLENREP (Biological) $42.23
- BRILINTA (Drug) $39.03
- TEFLARO (Drug) $25.44
- (5050) Extended Holter (Device) $19.65
- AVYCAZ (Drug) $16.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.